- Home
- ERNA vs DTIL Comparison
ERNA vs DTIL Comparison
Compare ERNA & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERNA
- DTIL
- Stock Information
- Founded
- ERNA 2018
- DTIL 2006
- Country
- ERNA United States
- DTIL United States
- Employees
- ERNA N/A
- DTIL N/A
- Industry
- ERNA Biotechnology: Pharmaceutical Preparations
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- ERNA Health Care
- DTIL Health Care
- Exchange
- ERNA Nasdaq
- DTIL Nasdaq
- Market Cap
- ERNA 56.4M
- DTIL 58.5M
- IPO Year
- ERNA N/A
- DTIL 2019
- Fundamental
- Price
- ERNA $0.84
- DTIL $7.62
- Analyst Decision
- ERNA
- DTIL Strong Buy
- Analyst Count
- ERNA 0
- DTIL 2
- Target Price
- ERNA N/A
- DTIL $39.50
- AVG Volume (30 Days)
- ERNA 89.2K
- DTIL 100.3K
- Earning Date
- ERNA 11-12-2024
- DTIL 11-04-2024
- Dividend Yield
- ERNA N/A
- DTIL N/A
- EPS Growth
- ERNA N/A
- DTIL N/A
- EPS
- ERNA N/A
- DTIL 1.45
- Revenue
- ERNA $598,000.00
- DTIL $75,096,000.00
- Revenue This Year
- ERNA N/A
- DTIL $59.44
- Revenue Next Year
- ERNA N/A
- DTIL N/A
- P/E Ratio
- ERNA N/A
- DTIL $3.94
- Revenue Growth
- ERNA 1072.55
- DTIL 43.62
- 52 Week Low
- ERNA $0.80
- DTIL $7.48
- 52 Week High
- ERNA $2.63
- DTIL $19.43
- Technical
- Relative Strength Index (RSI)
- ERNA 32.31
- DTIL 30.21
- Support Level
- ERNA $1.05
- DTIL $8.25
- Resistance Level
- ERNA $1.20
- DTIL $8.51
- Average True Range (ATR)
- ERNA 0.12
- DTIL 0.40
- MACD
- ERNA -0.01
- DTIL -0.05
- Stochastic Oscillator
- ERNA 7.76
- DTIL 8.43
About ERNA Eterna Therapeutics Inc.
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.